↓ Skip to main content

The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient’s dream study

Overview of attention for article published in Frontiers in oncology, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient’s dream study
Published in
Frontiers in oncology, September 2022
DOI 10.3389/fonc.2022.960387
Pubmed ID
Authors

Alessandra Fabi, Luana Fotia, Federico Giuseppini, Arianna Gaeta, Chiara Falcicchio, Gabriele Giuliani, Antonella Savarese, Emanuela Taraborelli, Valentina Rossi, Paola Malaguti, Diana Giannarelli, Patrizia Pugliese, Francesco Cognetti

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 7%
Student > Ph. D. Student 2 7%
Other 1 3%
Researcher 1 3%
Professor > Associate Professor 1 3%
Other 1 3%
Unknown 22 73%
Readers by discipline Count As %
Medicine and Dentistry 4 13%
Nursing and Health Professions 3 10%
Psychology 1 3%
Engineering 1 3%
Unknown 21 70%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2022.
All research outputs
#16,796,348
of 25,478,886 outputs
Outputs from Frontiers in oncology
#6,658
of 22,568 outputs
Outputs of similar age
#238,415
of 438,462 outputs
Outputs of similar age from Frontiers in oncology
#559
of 1,739 outputs
Altmetric has tracked 25,478,886 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,568 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,462 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,739 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.